23 results
8-K
EX-99.1
XENE
Xenon Pharmaceuticals Inc
8 Aug 23
Xenon Pharmaceuticals Expands Leadership on its Board of Directors with Appointments of Gillian M. Cannon and Justin Gover
4:07pm
Exhibit 99.1
NEWS RELEASE
Xenon Pharmaceuticals Expands Leadership on its Board of Directors with Appointments of
Gillian M. Cannon and Justin … in the pharmaceutical industry, where she served in business and commercial leadership roles at Merck and Co., UCB, Otsuka and Roivant. Mr. Gover served
8-K
EX-99.1
XENE
Xenon Pharmaceuticals Inc
7 Nov 22
Other Events
4:06pm
Exhibit 99.1
NEWS RELEASE
Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Andrea DiFabio
as Chief Legal Officer and Corporate … strategic leadership and oversight of the planning and execution for Xenon’s legal function on a global basis.
Mr. Ian Mortimer, Xenon’s President and Chief
8-K
EX-99.1
cu0594qnkh1imx
23 Aug 21
Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Dr. Christopher Kenney as Chief Medical Officer
8:33am
8-K
EX-10.2
u9vsmf
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-10.3
q3l8w29vlq
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-99.1
a07uxu7qagsndj jcx
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-10.4
px29b3ti4 pci
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-99.1
dpaii0 sbz2hjk
5 Nov 20
Xenon Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:11pm
8-K
EX-99.1
f6yndahlp6 v8y2t6
17 Aug 20
Xenon Pharmaceuticals Appoints Dr. Chris Von Seggern as Chief Commercial Officer
8:34am
8-K
EX-99.1
bdam47be61d
6 Aug 20
Xenon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
4:14pm
8-K
EX-10.1
eu04q4s1swy c7iy09
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
424B4
joip0dxc iag
5 Nov 14
Prospectus supplement with pricing info
12:00am